TY - JOUR AU - Liang, Guohua AU - Ma, Wenjie AU - Zhao, Yanfang AU - Liu, Eryu AU - Shan, Xiaoyu AU - Ma, Weiwei AU - Tang, Dabei AU - Li, Liru AU - Niu, Xingjian AU - Zhao, Wenhui AU - Zhang, Qingyuan PY - 2021 DA - 2021/04/07 TI - Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters JO - BMC Cancer SP - 362 VL - 21 IS - 1 AB - Hand-foot syndrome (HFS) is a side effect of skin related to pegylated liposomal doxorubicin (PLD) application. Moderate to severe hand-foot syndrome (MSHFS) might have a serious impact on patients’ quality of life and treatment. However, information on risk factors for the development of MSHFS is still limited. To analyze the risk factors for PLD-induced MSHFS in breast cancer patients and constructed a logistic regression prediction model. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-021-08028-8 DO - 10.1186/s12885-021-08028-8 ID - Liang2021 ER -